What is Dare Bioscience, Inc. Common Stock's Market Cap?

Dare Bioscience, Inc. Common Stock's Market Cap is $10.6M, based on as-reported figures from SEC (XBRL) filings.

What is Dare Bioscience, Inc. Common Stock's Enterprise Value?

Dare Bioscience, Inc. Common Stock's Enterprise Value is -$1.8M, based on as-reported figures from SEC (XBRL) filings.

What is Dare Bioscience, Inc. Common Stock's Price / Sales?

Dare Bioscience, Inc. Common Stock's Price / Sales is 7.8×, based on as-reported figures from SEC (XBRL) filings.

What is Dare Bioscience, Inc. Common Stock's EV / Revenue?

Dare Bioscience, Inc. Common Stock's EV / Revenue is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Dare Bioscience, Inc. Common Stock's EV / EBITDA?

Dare Bioscience, Inc. Common Stock's EV / EBITDA is 0.2×, based on as-reported figures from SEC (XBRL) filings.

What is Dare Bioscience, Inc. Common Stock's Revenue (TTM)?

Dare Bioscience, Inc. Common Stock's Revenue (TTM) is $1.4M, based on as-reported figures from SEC (XBRL) filings.

What is Dare Bioscience, Inc. Common Stock's Net Income (TTM)?

Dare Bioscience, Inc. Common Stock's Net Income (TTM) is -$11.0M, based on as-reported figures from SEC (XBRL) filings.

What is Dare Bioscience, Inc. Common Stock's EBITDA?

Dare Bioscience, Inc. Common Stock's EBITDA is -$9.0M, based on as-reported figures from SEC (XBRL) filings.

What is Dare Bioscience, Inc. Common Stock's Diluted EPS (TTM)?

Dare Bioscience, Inc. Common Stock's Diluted EPS (TTM) is -0.72, based on as-reported figures from SEC (XBRL) filings.

What is Dare Bioscience, Inc. Common Stock's EBITDA Margin?

Dare Bioscience, Inc. Common Stock's EBITDA Margin is -657.3%, based on as-reported figures from SEC (XBRL) filings.

Dare Bioscience, Inc. Common Stock (DARE) Financial Statements

Dare Bioscience, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001V0GDP9

XNAS · usd

0.70▼ 0.02 (-2.43%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close0.71

Day's Range0.70 – 0.74

52-Week Range0.69 – 3.78

Volume190.8K

Avg Volume637.5K

Share Statistics

Shares Outstanding

Employees24

ExchangeXNAS

Listed2014-04-10

Share count as of August 12, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Dare Bioscience, Inc. Common Stock (DARE)

What is Dare Bioscience, Inc. Common Stock's Market Cap?: Dare Bioscience, Inc. Common Stock's Market Cap is $10.6M, based on as-reported figures from SEC (XBRL) filings.
What is Dare Bioscience, Inc. Common Stock's Enterprise Value?: Dare Bioscience, Inc. Common Stock's Enterprise Value is -$1.8M, based on as-reported figures from SEC (XBRL) filings.
What is Dare Bioscience, Inc. Common Stock's Price / Sales?: Dare Bioscience, Inc. Common Stock's Price / Sales is 7.8×, based on as-reported figures from SEC (XBRL) filings.
What is Dare Bioscience, Inc. Common Stock's EV / Revenue?: Dare Bioscience, Inc. Common Stock's EV / Revenue is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Dare Bioscience, Inc. Common Stock's EV / EBITDA?: Dare Bioscience, Inc. Common Stock's EV / EBITDA is 0.2×, based on as-reported figures from SEC (XBRL) filings.
What is Dare Bioscience, Inc. Common Stock's Revenue (TTM)?: Dare Bioscience, Inc. Common Stock's Revenue (TTM) is $1.4M, based on as-reported figures from SEC (XBRL) filings.
What is Dare Bioscience, Inc. Common Stock's Net Income (TTM)?: Dare Bioscience, Inc. Common Stock's Net Income (TTM) is -$11.0M, based on as-reported figures from SEC (XBRL) filings.
What is Dare Bioscience, Inc. Common Stock's EBITDA?: Dare Bioscience, Inc. Common Stock's EBITDA is -$9.0M, based on as-reported figures from SEC (XBRL) filings.
What is Dare Bioscience, Inc. Common Stock's Diluted EPS (TTM)?: Dare Bioscience, Inc. Common Stock's Diluted EPS (TTM) is -0.72, based on as-reported figures from SEC (XBRL) filings.
What is Dare Bioscience, Inc. Common Stock's EBITDA Margin?: Dare Bioscience, Inc. Common Stock's EBITDA Margin is -657.3%, based on as-reported figures from SEC (XBRL) filings.